Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13631
Country/Region: Côte d'Ivoire
Year: 2017
Main Partner: Ariel Glaser Pediatric AIDS Healthcare Initiative
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 332,396
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 2,118
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 2,381
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 2,355
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 15,202
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 5,012
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 4,230
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 35,612
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 2,064
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 2,038
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 13,294
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 4,380
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 20,518
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 20,540
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 142,910
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 47,328
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 282
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 273
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 1,668
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 561
HTS_TST Sum of Test Result disaggregates 2018 9,676
HTS_TST_POS By Test Result: Positive 2018 9,676
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 417
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 421
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 2,884
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 939
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: <15, Positive 2018 57
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 503
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 6
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 79
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 20
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 177
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 176
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 2,479
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 1,370
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 102
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 26
PMTCT_ART Already on ART at beginning of current pregnancy 2018 408
PMTCT_ART New on ART 2018 767
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,175
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 47,556
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,108
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 224
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 880
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 2
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 2
PMTCT_STAT By Age (Numerator): 10-14 2018 123
PMTCT_STAT By Age (Numerator): 15-19 2018 4,209
PMTCT_STAT By Age (Numerator): 20-24 2018 7,817
PMTCT_STAT By Age (Numerator): 25-49 2018 35,384
PMTCT_STAT By Age (Numerator): 50+ 2018 21
PMTCT_STAT By Age (Numerator): Unknown Age 2018 1
PMTCT_STAT By Number of known positives: 15-19 2018 2
PMTCT_STAT By Number of known positives: 20-24 2018 41
PMTCT_STAT By Number of known positives: 25-49 2018 503
PMTCT_STAT By Number of known positives: 50+ 2018 1
PMTCT_STAT By Number of new negative: 10-14 2018 121
PMTCT_STAT By Number of new negative: 15-19 2018 4,129
PMTCT_STAT By Number of new negative: 20-24 2018 7,743
PMTCT_STAT By Number of new negative: 25-49 2018 34,358
PMTCT_STAT By Number of new negative: 50+ 2018 19
PMTCT_STAT By Number of new negative: Unknown Age 2018 1
PMTCT_STAT By Number of new positives: 15-19 2018 17
PMTCT_STAT By Number of new positives: 20-24 2018 63
PMTCT_STAT By Number of new positives: 25-49 2018 557
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 47,556
PMTCT_STAT_den By Age (Denominator): <15-19 2018 2,494
PMTCT_STAT_den By Age (Denominator): 10-14 2018 96
PMTCT_STAT_den By Age (Denominator): 20-24 2018 5,250
PMTCT_STAT_den By Age (Denominator): 25-49 2018 31,440
PMTCT_STAT_den By Age (Denominator): 50+ 2018 12
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 9,233
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 5
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 422
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 303
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 761
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 733
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 5
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 439
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 313
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 43
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,544
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 49
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,833
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 3,469
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 3,561
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 44
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,589
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 49
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,879
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 161
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 139
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 5,742
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 2,225
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 9,030
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 8,267
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 46,262
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 766
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 5
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 3
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 433
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 324
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 763
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 555
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 26,062
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 18,879
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 601
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 614
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 3,489
TX_TB_den Denominator: By Screen Result: Negative 2018 41,624
TX_TB_den Denominator: By Screen Result: Positive 2018 4,638
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 4,638